U.S. Overdose Deaths Drop 10% in Early Data

Follow Drugslib on

Medically reviewed by Drugs.com.

By Robin Foster HealthDay Reporter

MONDAY, Oct. 7, 2024 -- In findings that suggest inroads are being made in the battle against America's opioid epidemic, new government data shows a 10% drop in overdose deaths.

The statistics, compiled by states and posted by the U.S. Centers for Disease Control and Prevention, show just over 100,000 people died of a drug overdose during the 12-month period ending in April 2024.

Dr. Rahul Gupta, director of the White House Office of National Drug Control Policy, described the drop as the largest on record and credited the administration’s dual strategies of beefing up public health interventions while cracking down on drug suppliers.

“This has not happened by accident,” Gupta told the Washington Post.

Experts also credited the widespread availability of the overdose antidote naloxone, the Post reported.

But there is also a less sunny analysis of the decline: Because fentanyl took so many lives in recent years, the group of potential victims has shrunk, Dr. Daniel Ciccarone, a researcher at the University of California, San Francisco School of Medicine who studies overdose trends, speculated to the Post.

Importantly, the CDC data remains preliminary and could change because state data lags as coroners and medical examiners conclude death investigations.

Overdoses reached historic rates in recent years as fentanyl took over the nation’s heroin supply, the Post reported. Overdose deaths in 2021 topped 100,000 nationally for the first time. In 2022, the spike slowed but still reached nearly 110,000 confirmed deaths, a record high.

Last year, an estimated 108,318 people died in what federal officials described as the first annual decrease in deaths since 2018.

Even that 2018 dip had been fleeting, as fatalities rose again and spiked during the pandemic, the Post reported.

Still, the 2018 decrease was more gradual while the recent drop has been steep, said Nabarun Dasgupta, a senior scientist at the University of North Carolina at Chapel Hill's Injury Prevention Center. Overdoses not resulting in death have also decreased in many states, Dasgupta told the Post.

Dasgupta said he believes that by the end of 2024, there could be 20,000 fewer deaths than the year before.

“This will be a historic moment for public health. Something has changed -- that I’m sure of,” Dasgupta said. “Where the direction lines go from here, I have no idea.”

Dasgupta theorized that changes in the illicit drug supply may be playing a major role.

Other drugs are appearing alongside fentanyl, depending on the region. In some cases, drug dealers add the tranquilizer xylazine to fentanyl. The tranquilizer prolongs the sedating effect and staves off opioid withdrawal so that users may consume less fentanyl each day, experts suggest.

While the latest CDC data does not include demographics, a recent analysis from the health policy research organization KFF compared fatal overdoses from the second half of 2023 to the same period the year before and found deaths decreased among most racial and ethnic groups.

Still, white people experienced a more significant decline in deaths than other groups, KFF policy analyst Heather Saunders, who wrote the analysis, told the Post.

Sources

  • U.S. Centers for Disease Control and Prevention, data, Oct. 7, 2024
  • Washington Post

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2024-10-08 00:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords